These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37332121)
1. Characterization and clinical implications of different malignant transformation patterns in diffuse low-grade gliomas. Jiang H; Zhu Q; Wang X; Li M; Shen S; Yang C; Zhao X; Li M; Ma G; Zhao X; Chen X; Yang J; Lin S Cancer Sci; 2023 Sep; 114(9):3708-3718. PubMed ID: 37332121 [TBL] [Abstract][Full Text] [Related]
2. Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis. Familiari P; Lapolla P; Picotti V; Palmieri M; Pesce A; Carosi G; Relucenti M; Nottola S; Gianno F; Minasi S; Antonelli M; Frati A; Santoro A; D'Andrea G; Bruzzaniti P; LA Pira B Anticancer Res; 2023 Jun; 43(6):2659-2670. PubMed ID: 37247932 [TBL] [Abstract][Full Text] [Related]
3. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance. Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548 [TBL] [Abstract][Full Text] [Related]
4. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas. Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263 [TBL] [Abstract][Full Text] [Related]
5. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection. Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276 [TBL] [Abstract][Full Text] [Related]
6. Impact of 1p/19q codeletion status on extent of resection in WHO grade II glioma: Insights from a national cancer registry. Lu VM; Alvi MA; Bydon M; Quinones-Hinojosa A; Chaichana KL Clin Neurol Neurosurg; 2019 Jul; 182():32-36. PubMed ID: 31063969 [TBL] [Abstract][Full Text] [Related]
7. An extent of resection threshold for seizure freedom in patients with low-grade gliomas. Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599 [TBL] [Abstract][Full Text] [Related]
8. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas. Etxaniz O; Carrato C; de Aguirre I; Queralt C; Muñoz A; Ramirez JL; Rosell R; Villà S; Diaz R; Estival A; Teixidor P; Indacochea A; Ahjal S; Vilà L; Balañá C J Neurooncol; 2017 Nov; 135(2):273-284. PubMed ID: 28884377 [TBL] [Abstract][Full Text] [Related]
9. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071 [TBL] [Abstract][Full Text] [Related]
10. Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas. Sabha N; Knobbe CB; Maganti M; Al Omar S; Bernstein M; Cairns R; Çako B; von Deimling A; Capper D; Mak TW; Kiehl TR; Carvalho P; Garrett E; Perry A; Zadeh G; Guha A; Sidney Croul Neuro Oncol; 2014 Jul; 16(7):914-23. PubMed ID: 24470545 [TBL] [Abstract][Full Text] [Related]
11. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas. Yang X; Lin Y; Xing Z; She D; Su Y; Cao D Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488 [TBL] [Abstract][Full Text] [Related]
12. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
13. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. Sanai N; Polley MY; Berger MS J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970 [TBL] [Abstract][Full Text] [Related]
14. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma. Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519 [TBL] [Abstract][Full Text] [Related]
19. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas. Peng X; Yishuang C; Kaizhou Z; Xiao L; Ma C J Comput Assist Tomogr; 2019; 43(2):269-276. PubMed ID: 30371623 [TBL] [Abstract][Full Text] [Related]
20. MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Zhou H; Vallières M; Bai HX; Su C; Tang H; Oldridge D; Zhang Z; Xiao B; Liao W; Tao Y; Zhou J; Zhang P; Yang L Neuro Oncol; 2017 Jun; 19(6):862-870. PubMed ID: 28339588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]